Author Question: If the par value of a bond is equal to the bond price, then we know the yield to maturity is equal ... (Read 71 times)

tuffie

  • Hero Member
  • *****
  • Posts: 534
If the par value of a bond is equal to the bond price, then we know the yield to maturity is equal to the coupon rate.
 
  Indicate whether the statement is true or false.

Question 2

Southern Transit Corporation has 1,000 par value, twenty-year, 6 annual coupon bonds, outstanding currently selling for 696.25. What is the yield to maturity on these bonds? Use a calculator for your answer.
 
  What will be an ideal response?



briezy

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

Answer: TRUE

Answer to Question 2

Answer: 9.43. FV = 1,000; PMT = 1,000  .06 = 60; N = 20; PV = 696.25. CPT 1/Y to get 9.43.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library